Inventor

Michael F. Concino

Inventor
Bolton, MA, US

Overview

27→
Patents
1993–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 27 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
C07KPeptides20%
C12NMicroorganisms or enzymes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C12YEnzymes13%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
Y02ATechnologies for adaptation to climate change3%
A01KAnimal husbandry2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture1%
PatentTitleYear
11,065,307Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety202110,729,746Recombinant placenta growth factor for treating Duchenne muscular dystrophy202010,722,559Mannose-6-phosphate bearing peptides fused to lysosomal enzymes202010,603,364Lysosomal targeting and uses thereof202010,556,015Lysosomal targeting of enzymes, and uses thereof20209,932,377Mitochondrial targeting and therapeutic use thereof20189,932,568Peptide linkers for polypeptide compositions and methods for using same20189,814,764'Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidase'20179,708,590'Crystal structure of human α-N-acetylglucosaminidase'20179,597,376'Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitis'20179,453,847'Mannose receptor C type 1 (MRC1) codon optimized cell line and uses thereof'20169,260,495'Mitochondrial targeting and therapeutic use thereof'20169,206,235'Peptide linkers for polypeptide compositions and methods for using same'20158,945,542'Methods for treating lysosomal acid lipase deficiency'20158,775,146'Crystal structure of human alpha-N-acetylglucosaminidase'20148,580,922'Peptide linkers for polypeptide compositions and methods for using same'20137,229,793'Constructs and cells for production of small peptides'20076,858,578'Chimeric proteins for use in transport of a selected substance into cells'20056,316,604'Human C3b/C4b receptor (CR1)'20016,262,026'Chimeric proteins for use in transport of a selected substance into cells'20016,027,921'Chimeric proteins for use in transport of a selected substance into cells and DNA encoding chimeric proteins'20005,981,481'Human C3b/C4b receptor (CR1)'19995,856,297'Human C3b/C4b receptor (CR1)'19995,817,789'Chimeric proteins for use in transport of a selected substance into cells'19985,472,939'Method of treating complement mediated disorders'19955,256,642'Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof'19935,212,071'Nucleic acids encoding a human C3b/C4b receptor (CR1)'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–1999Patents assigned to BRIGHAM & WOMENS HOSPITAL (5)· patent assignee history
1993–1999Patents assigned to UNIV JOHNS HOPKINS (5)· patent assignee history
1993–1999Patents assigned to T CELL SCIENCES INC (4)· patent assignee history
1993–2005Based in Newton, MA, US· patent location history
1998–2005Patents assigned to TRANSKARYOTIC THERAPIES INC (4)· patent assignee history
2007–2021Patents assigned to SHIRE HUMAN GENETIC THERAPIES (16)· patent assignee history
2007–2021Based in Bolton, MA, US· patent location history
2020Based in Lexington, MA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SHIRE HUMAN GENETIC THERAPIES162007–2021
BRIGHAM & WOMENS HOSPITAL51993–1999
UNIV JOHNS HOPKINS51993–1999
T CELL SCIENCES INC41993–1999
TRANSKARYOTIC THERAPIES INC41998–2005
Locations
LocationPatentsSpan
Bolton, Massachusetts, US132007–2021
Newton, Massachusetts, US101993–2005
Lexington, Massachusetts, US42020